Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Questions Surface In Response To FDA's Draft Guidance On Device Animal Studies

This article was originally published in The Gray Sheet

Executive Summary

Industry and regulatory groups say FDA should make it clearer in a final guidance whether it intends to only address animal studies assessing safety or if it is also targeting performance studies in a draft guidance from October. There are also questions about reporting of raw data from animal studies, and PETA weighs in.

Advertisement

Related Content

J&J Pledges To Stop Animal Use In Sales Training

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register